Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no user-visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor platform update with no visible changes to the page content or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' to the page. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' from the page.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision updated to v3.3.4; the previous revision v3.3.3 is replaced.SummaryDifference0.1%

- Check59 days agoChange DetectedThe study locations section now includes Louisiana as a location to indicate where the trial is conducted.SummaryDifference0.2%

- Check87 days agoChange DetectedPublications section wording updated to indicate PubMed-based publication notes and the revision label updated to v3.3.2, replacing the previous note and v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.